Company page

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. is a public company listed under the ticker SYRE, operating in the American market. With a market capitalization of approximately $7.67 billion, the company focuses on developing innovative therapeutic solutions. Spyre Therapeutics is committed to advancing healthcare through its research and development efforts.